Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Gao, Qing ^a   Guo, Maojuan ^a   Zeng, Wenyun ^a   Wang, Yijing ^a   Yang, Lin ^a   Pang, Xiaoli ^a   Li, Huhu ^a   Suo, Yanrong ^a   Jiang, Xijuan ^a   Yu, Chunquan ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIAC FIBROBLAST; CARDIAC STEM CELL; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; ENZYME RELEASE; FIBROBLAST; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT;

MAMMALIA;

EID: 84924209625     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/836390     Document Type: Article

References (39)

1. K. U. Hong and R. Bolli, "Cardiac stem cell therapy for cardiac repair," Current Treatment Options in Cardiovascular Medicine, vol. 16, no. 7, article 324, 2014.
2. V. di Felice, A. de Luca, M. L. Colorito et al., "Cardiac stem cell research: an elephant in the room?" Anatomical Record, vol. 292, no. 3, pp. 449-454, 2009.
3. S. X. Liang and W. D. Phillips, "Migration of resident cardiac stem cells inmyocardial infarction," The Anatomical Record, vol. 296, no. 2, pp. 184-191, 2013.
4. K. Wang, X. Zhao, C. Kuang et al., "Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway," PLoS ONE, vol. 7, no. 9, Article ID e43922, 2012.
5. I. Cerrada, A. Ruiz-Saurí, R. Carrero et al., "Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair," Stem Cells and Development, vol. 22, no. 3, pp. 501-511, 2013.
6. F. Sanada, J. Kim, A. Czarna et al., "C-kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the agingmyopathy," Circulation Research, vol. 114, no. 1, pp. 41-55, 2014.
7. Y. Ma, L. E. de Castro Brás, H. Toba et al., "Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling," Pflugers Archiv European Journal of Physiology, vol. 466, no. 6, pp. 1113-1127, 2014.
8. C. A. Souders, S. L. K. Bowers, and T. A. Baudino, "Cardiac fibroblast: the renaissance cell," Circulation Research, vol. 105, no. 12, pp. 1164-1176, 2009.
9. T. A. Wynn, "Cellular and molecular mechanisms of fibrosis," Journal of Pathology, vol. 214, no. 2, pp. 199-210, 2008.
10. K. E. Porter and N. A. Turner, "Cardiac fibroblasts: at the heart of myocardial remodeling," Pharmacology & Therapeutics, vol. 123, no. 2, pp. 255-278, 2009.
11. M. Abrial, C.C. Da Silva, B. Pillot et al., "Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury," Journal of Molecular and Cellular Cardiology, vol. 68, pp. 56-65, 2014.
12. A. P. Beltrami, L. Barlucchi, D. Torella et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration," Cell, vol. 114, no. 6, pp. 763-776, 2003.
13. K. Urbanek, D. Torella, F. Sheikh et al., "Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8692-8697, 2005.
14. J. C. Garbern and R. T. Lee, "Cardiac stem cell therapy and the promise of heart regeneration," Cell Stem Cell, vol. 12, no. 6, pp. 689-698, 2013.
15. C. Bearzi, M. Rota, T. Hosoda et al., "Human cardiac stemcells," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068-14073, 2007.
16. A. Linke, P. Müller, D. Nurzynska et al., "Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarctedmyocardium, improving cardiac function," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8966-8971, 2005.
17. R. Bolli, A. R. Chugh, D. D'Amario et al., "Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial," The Lancet, vol. 378, no. 9806, pp. 1847-1857, 2011.
18. A. Oikonomopoulos, K.-I. Sereti, and R. Liao, "Resident cardiac stem/progenitor cells for cardiac regeneration," Drug Discovery Today:Therapeutic Strategies, vol. 5, no. 4, pp. 193-199, 2008.
19. B. Dawn, A. B. Stein, K. Urbanek et al., "Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarctedmyocardium, and improve cardiac function," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3766-3771, 2005.
20. X. L. Tang, G. Rokosh, S. K. Sanganalmath et al., "Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction," Circulation, vol. 121, no. 2, pp. 293-305, 2010.
21. B. Dawn, A. B. Stein, K. Urbanek et al., "Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarctedmyocardium, and improve cardiac function," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3766-3771, 2005.
22. H. Kawada, J. Fujita, K. Kinjo et al., "Intracoronary administration of cardiac stemcells improves cardiac function in pigs with old infarction," Circulation, vol. 114, no. 18, supplement 2, p. II-239, 2006.
23. K. Urbanek, M. Rota, S. Cascapera et al., "Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival," Circulation Research, vol. 97, no. 7, pp. 663-673, 2005.
24. T.-S. Yeh, Y.-H. Dean Fang, C.-H. Lu et al., "Baculovirustransduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction," Biomaterials, vol. 35, no. 1, pp. 174-184, 2014.
25. V. Chintalgattu, D. M. Nair, and L. C. Katwa, "Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR," Journal of Molecular and Cellular Cardiology, vol. 35, no. 3, pp. 277-286, 2003.
26. B. Heissig, K. Hattori, S. Dias et al., "Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand," Cell, vol. 109, no. 5, pp. 625-637, 2002.
27. A. Marsano, R. Maidhof, J. Luo et al., "The effect of controlled expression of VEGF by transducedmyoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction," Biomaterials, vol. 34, no. 2, pp. 393-401, 2013.
28. N. I. Chaudhary, G. J. Roth, F. Hilberg et al., "Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis," European Respiratory Journal, vol. 29, no. 5, pp. 976-985, 2007.
29. J. Tang, J. Wang, X. Kong et al., "Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway," Experimental Cell Research, vol. 315, no. 20, pp. 3521-3531, 2009.
30. M. Grunewald, I. Avraham, Y. Dor et al., "VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells," Cell, vol. 124, no. 1, pp. 175-189, 2006.
31. F. Claes, W. Vandevelde, L. Moons, and M. Tjwa, "Another angiogenesis-independent role for VEGF: SDF1-dependent cardiac repair via cardiac stem cells," Cardiovascular Research, vol. 91, no. 3, pp. 369-370, 2011.
32. J. Guo, W. Jie, Z. Shen et al., "SCF increases cardiac stem cell migration through PI3K/AKT and MMP-2/-9 signaling," International Journal of Molecular Medicine, vol. 34, pp. 112-118, 2014.
33. X. Liu, B. Duan, Z. Cheng et al., "SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion," Protein & Cell, vol. 2, no. 10, pp. 845-854, 2011.
34. M. Iwasaki, M. Koyanagi, H. Kossmann et al., "Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblasts," European Heart Journal, vol. 32, no. 5, pp. 627-636, 2011.
35. G. M. Ellison, D. Torella, S. Dellegrottaglie et al., "Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart," Journal of the American College of Cardiology, vol. 58, no. 9, pp. 977-986, 2011.
36. J.-M. Tang, J.-N. Wang, L. Zhang et al., "VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart," Cardiovascular Research, vol. 91, no. 3, pp. 402-411, 2011.
37. J. D. Abbott, Y. Huang, D. Liu, R. Hickey, D. S. Krause, and F. J. Giordano, "Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart aftermyocardial infarction but is not sufficient to induce homing in the absence of injury," Circulation, vol. 110, no. 21, pp. 3300-3305, 2004.
38. B. Huang, J. Qian, J. Ma et al., "Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction," Stem Cell Research and Therapy, vol. 5, no. 1, article 22, 2014.
39. H. Nikami, J. Nedergaard, and J. M. Fredriksson, "Norepinephrine but not hypoxia stimulates HIF-1α gene expression in brown adipocytes," Biochemical and Biophysical Research Communications, vol. 337, no. 1, pp. 121-126, 2005.